New funds, new classes, and new opportunities for mentorship — these are this week's Houston innovators to know. Courtesy photos

While last week's innovators to know were all starting new jobs, these three for this week are starting new endeavors — from multi-million-dollar funds to education programs. Here are this week's three innovators to know.

Barbara Burger, president of Chevron Technology Ventures

Courtesy of CTV

Houston-based Chevron Technology Ventures announced a new $90 million fund to focus scalable tech companies that could improve and advance Chevron's oil and gas business.

Leading Fund VII is CTV president, Barbara Burger. According to the release, the fund will target early- to mid-stage companies and limited partnership funds.

"CTV serves as an excellent source within Chevron for new business models and novel technologies that can deliver value to the enterprise through their integration," Burger says in the release. "We are using venture capital as a conduit for early access to innovation and to build a pipeline of innovation for Chevron." Read the full story here.

Anthony Ambler, dean of the College of Technology at the University of Houston

Courtesy of UH

Undergraduate students at the University of Houston now have the option to major or minor in Technology Leadership and Innovation Management or minor in Applied Innovation, thanks, in part, to the College of Technology dean Anthony P. Ambler. All three options begin in the fall semester of this year, and the college is also interested in adding a master's and a PhD. program in Innovation Management or a post-graduate certificate program.

"We are about giving people the right tools to innovate," says Ambler in a release. "How do you get more people to the position where they are able to innovate?" Read the full story here.

Myrtle Jones, senior vice president at Halliburton

Courtesy of Myrtle Jones

Despite climbing through the ranks within the energy industry, Myrtle Jones says mentorship wasn't a big priority when she was in the early part of her career.

"I started working in the energy business in the early '80s, and women were new to the industry," Jones says. "We were somewhat getting ourselves established in the business world – there was no such thing as someone saying, 'We're going to get you linked up with mentors,' so you had to find role models."

Now, Jones has teamed up with Austin-based tech company, Bumble Bizz, that helps connect industry professionals and foster networking and mentoring opportunities. As of 2019, users have the option to see only women on the app, too, in order to foster their professional network of women. Read the full story here.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Austin company to bring AI-powered school to The Woodlands

AI education

Austin-based Alpha School, which operates AI-powered private schools, is opening its first Houston-area location in The Woodlands.

The 8,000-square-foot school, scheduled to be ready for the 2026-27 academic year, initially will serve students in kindergarten through eighth grade. Alpha says the school will offer “open workshop spaces and innovative classrooms that support personalized instruction, core academics, leadership development, and real-world life skills.”

Alpha sets aside two hours each school day for the AI-driven, self-paced study of core subjects like math, reading and science. The rest of each school day consists of life-skills workshops focusing on topics such as leadership and financial literacy.

Alpha’s school in The Woodlands has begun accepting applications for the 2026-27 school year. Annual tuition costs $40,000.

“The Woodlands is one of the most dynamic, forward-thinking communities in Texas, and Alpha is proud to bring

an innovative educational model that complements its strong academic foundation,” says Rachel Goodlad, head

of expansion for Alpha.

Founded in 2014, Alpha School combines adaptive technology-driven instruction with immersive life-skills workshops. Its model emphasizes mastery-based learning in core subjects alongside development of communication, critical thinking, financial literacy and leadership skills. It operates more than 15 schools across the country.

Elsewhere in Texas, Alpha operates schools in Austin, Brownsville, Fort Worth and Plano. Alpha also operates 12 Texas Sports Academy campuses in Texas, including locations in Houston, Pearland and Richmond, along with a NextGen Academy esports school in Austin, a school for gifted students in Georgetown, and lower-cost Nova Academy campuses in Austin and Bastrop.

Alpha has fans and critics. While supporters tout students’ high achievement rates, detractors complain about the high tuition and the AI-influenced depersonalization of education.

“Students and our country need to be in relationship with other human beings,” Randi Weingarten, president of the American Federation of Teachers, a teachers union, tells The New York Times. “When you have a school that is strictly AI, it is violating that core precept of the human endeavor and of education.”

Alpha co-founder MacKenzie Price, a podcaster and social media influencer, doesn’t share Weingarten’s views.

“Parents and teachers: We need to embrace this change,” Price wrote after President Trump signed an executive order promoting AI in schools.

The Times notes that Alpha doesn’t employ AI as a tutor or a supplement. Rather, the newspaper says, AI is “the school’s primary educational driver to move students through academic content.”

Houston researcher secures $1.7M to develop drug for aggressive form of breast cancer

cancer research

A University of Houston researcher has joined a $3.2 million effort to develop a new drug designed to attack a cancer-driving protein commonly found in triple-negative breast cancer.

Triple-negative breast cancer (TNBC) is one of the most difficult-to-treat forms of cancer and accounts for 10 percent to 15 percent of all breast cancer cases. The disease gets its name because tumors associated with it test negative for estrogen receptors, progesterone receptors and excess HER2 protein, making it difficult to target. Due to this, TNBC is often treated with general chemotherapy, which can come with negative side effects and drug resistance, according to UH.

UH College of Pharmacy research associate professor Wei Wang is developing a drug that can target the disease more specifically. The drug will target MDM2, a protein often overproduced in TNBC that also contributes to faster tumor growth.

Wang is working on a team led by Wei Li, director of the University of Tennessee Health Science Center College of Pharmacy’s Drug Discovery Center. She has received $1.7 million to support the research.

Wang and UH professor of pharmacology and toxicology Ruiwen Zhang have discovered a compound that can break down MDM2. In early laboratory models, the compound has shown the ability to shrink tumors.

Wang and Zhang will focus on understanding how the treatment works and monitoring its effectiveness in models that closely mirror human disease.

“We will study how the drug targets MDM2 and evaluate the most promising drug candidates to determine effective dosing, understand how the drug behaves in the body, compare it with existing treatments and assess early safety,” Wang said in a news release.

Li’s team at the University of Tennessee will be working on the chemistry and drug design end of the project.

“This work could lead to an entirely new class of therapies for triple-negative breast cancer,” Li added in the release. “We’re hopeful that by directly removing the MDM2 protein from cancer cells, we can help more patients respond to treatment regardless of their tumor type.”